Informations:
Erreur:
ID
14821
Description
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01625286
Lien
https://clinicaltrials.gov/show/NCT01625286
Mots-clés
Versions (1)
- 29/04/2016 29/04/2016 -
Téléchargé le
29 avril 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Advanced or Metastatic Breast Cancer, NCT01625286
Eligibility Advanced or Metastatic Breast Cancer, NCT01625286
- StudyEvent: Eligibility
Similar models
Eligibility Advanced or Metastatic Breast Cancer, NCT01625286
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
female patient
Item
female patient
boolean
C0150905 (UMLS CUI [1])
age
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
histological or cytological confirmation of breast cancer with evidence of advanced or metastatic disease (must be er+ve, her2-ve, in part b).
boolean
C0678222 (UMLS CUI [1])
who performance status
Item
world health organisation (who) performance status 0-1 with no deterioration over the previous 2 weeks and minimum life expectancy of 12 weeks.
boolean
C1298650 (UMLS CUI [1])
clinically significant abnormalities of glucose metabolism
Item
clinically significant abnormalities of glucose metabolism
boolean
C0744434 (UMLS CUI [1])
spinal cord compression
Item
spinal cord compression or brain metastases unless asymptomatic, treated and stable (not requiring steroids).
boolean
C0037926 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0220650 (UMLS CUI [2])
systemic diseases, bleeding diatheses
Item
evidence of severe or uncontrolled systemic diseases, including active bleeding diatheses or active infections including hepatitis b, c and hiv.
boolean
C1536063 (UMLS CUI [1])
C0442893 (UMLS CUI [2])
C0442893 (UMLS CUI [2])
inhibit akt
Item
any prior exposure to agents which inhibit akt as the primary pharmacological activity.
boolean
C0812228 (UMLS CUI [1])
chemotherapy
Item
part a: more than two prior courses of chemotherapy (including taxanes) for advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1])
chemotherapy
Item
part b: any prior chemotherapy for advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,2])